Karcinoide tumorer og gobletcelle-karcinoide tumorer i appendix
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Karcinoide tumorer og gobletcelle-karcinoide tumorer i appendix. / Knigge, Ulrich; Hansen, Carsten Palnaes.
In: Ugeskrift for Laeger, Vol. 172, No. 22, 31.05.2010, p. 1678-81.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Karcinoide tumorer og gobletcelle-karcinoide tumorer i appendix
AU - Knigge, Ulrich
AU - Hansen, Carsten Palnaes
PY - 2010/5/31
Y1 - 2010/5/31
N2 - Appendiceial carcinoid tumors (CAT) and goblet cell carcinoids (GCCAT) are rare. Most are asymptomatic and found after appendectomy. Metastases to regional nodes are seen in 10% of CATs larger than two cm. Ovarian or peritoneal metastases are seen in 20% of all GCCATs. Further surgical treatments are shown in Tables. Non-resectable CAT are treated with interferon-alpha, somatostatin analogs or radionuclides. Non-resectable GCCATs are treated like colo-rectal cancer. Patients with CAT larger than two cm, involvement of mesoappendix or metastases and all GCCAT should be followed life-long.
AB - Appendiceial carcinoid tumors (CAT) and goblet cell carcinoids (GCCAT) are rare. Most are asymptomatic and found after appendectomy. Metastases to regional nodes are seen in 10% of CATs larger than two cm. Ovarian or peritoneal metastases are seen in 20% of all GCCATs. Further surgical treatments are shown in Tables. Non-resectable CAT are treated with interferon-alpha, somatostatin analogs or radionuclides. Non-resectable GCCATs are treated like colo-rectal cancer. Patients with CAT larger than two cm, involvement of mesoappendix or metastases and all GCCAT should be followed life-long.
M3 - Tidsskriftartikel
VL - 172
SP - 1678
EP - 1681
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 22
ER -
ID: 34052460